The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...
from NDTV News - Special https://ift.tt/3jjsiDu
Subscribe to:
Post Comments (Atom)
Why 2 spice cos are in global regulatory soup
The spice industry is facing growth challenges due to regulatory actions against MDH and Everest brands for ethylene oxide contamination. Bo...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Trading in stock markets this week will be majorly influenced by the upcoming quarterly earnings from IT majors TCS and Infosys, along with...
No comments:
Post a Comment